GRI Bio, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRI Bio, Inc and other ETFs, options, and stocks.About GRI
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
CEOW. Marc Hertz
CEOW. Marc Hertz
Employees4
Employees4
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2009
Founded2009
Employees4
Employees4
GRI Key Statistics
Market cap1.97M
Market cap1.97M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume1.80M
Average volume1.80M
High today$0.3574
High today$0.3574
Low today$0.3287
Low today$0.3287
Open price$0.3287
Open price$0.3287
Volume175.55K
Volume175.55K
52 Week high$15.64
52 Week high$15.64
52 Week low$0.305
52 Week low$0.305
Stock Snapshot
GRI Bio, Inc(GRI) stock is priced at $0.33, giving the company a market capitalization of 1.97M. It carries a P/E multiple of -0.02.
During the trading session on 2025-12-26, GRI Bio, Inc(GRI) shares reached a daily high of $0.36 and a low of $0.33. At a current price of $0.33, the stock is +1.2% higher than the low and still -6.9% under the high.
Trading activity shows a volume of 175.55K, compared to an average daily volume of 1.8M.
The stock's 52-week range extends from a low of $0.31 to a high of $15.64.
The stock's 52-week range extends from a low of $0.31 to a high of $15.64.
People also own
Based on the portfolios of people who own GRI. This list is generated using Robinhood data, and it’s not a recommendation.